Meeting Register Page

CMS Aduhelm Proposal
Dear Penn Memory Center friends and family, 

The Centers for Medicare and Medicaid Services (CMS) just released a proposal to cover the Alzheimer's disease drug Aduhelm (formerly aducanumab) exclusively for those participating in qualifying clinical trials.

Please join us for a virtual community discussion about this proposal at 4 p.m. Wednesday, January 19. Penn Memory Center (PMC) Co-Director Jason Karlawish, MD, and UPenn Medicare expert Allison K. Hoffman, JD, will review the proposal and its potential impact on PMC, our research participants, and our patients. 

Jan 19, 2022 04:00 PM in Eastern Time (US and Canada)

Loading
* Required information